Singh, A. and Singh, P. 2016. TERIFLUNOMIDE: A NOVEL ORAL DISEASE-MODIFYING AGENT UNDER INVESTIGATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS. Journal of Drug Delivery and Therapeutics. 6, 5 (Sep. 2016), 97–102. DOI:https://doi.org/10.22270/jddt.v6i5.1303.